Vitamin K Concept

subject area of

• 15 Side-effects of antithrombotic therapy  Journal Articles
• 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer  Journal Articles
• 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII  Journal Articles
• d-Dimer Testing to Determine the Duration of Anticoagulation Therapy  Journal Articles
• A Food Frequency Questionnaire for the Assessment of Calcium, Vitamin D and Vitamin K: A Pilot Validation Study  Journal Articles
• A Replacement for Warfarin  Journal Articles
• A novel long‐acting synthetic factor Xa inhibitor (SanOrg34006) to replace warfarin for secondary prevention in deep vein thrombosis. A Phase II evaluation  Journal Articles
• A randomised, double blind comparison of tecarfarin, a novel vitamin K antagonist, with warfarin  Journal Articles
• ANTICOAGULANTS AND OTHER DRUGS IN THROMBOSIS  Journal Articles
• Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012  Journal Articles
• Advances in the management of venous thromboembolism  Journal Articles
• Advances in the management of venous thromboembolism.  Journal Articles
• American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy  Journal Articles
• Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis  Journal Articles
• Anticoagulants in Venous Thromboembolism  Journal Articles
• Anticoagulants in heart disease: current status and perspectives  Journal Articles
• Anticoagulants in pregnancy: A review of indications and complications  Journal Articles
• Anticoagulation Control with Daily Low‐Dose Vitamin K to Reduce Clinically Adverse Outcomes and International Normalized Ratio Variability: A Systematic Review and Meta‐Analysis  Journal Articles
• Anticoagulation for patients with cancer and central venous catheters  Journal Articles
• Anticoagulation for people with cancer and central venous catheters  Journal Articles
• Anticoagulation for people with cancer and central venous catheters  Journal Articles
• Anticoagulation for people with cancer and central venous catheters  Journal Articles
• Anticoagulation for pregnant women with mechanical heart valves: a systematic review and meta-analysis  Journal Articles
• Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer  Journal Articles
• Anticoagulation for the initial treatment of venous thromboembolism in people with cancer  Journal Articles
• Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer  Journal Articles
• Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer  Journal Articles
• Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters  Journal Articles
• Antiplatelet versus oral anticoagulant therapy as antithrombotic prophylaxis after mitral valve repair  Journal Articles
• Antithrombotic Drugs  Journal Articles
• Antithrombotic Therapy for Atrial Fibrillation  Journal Articles
• Antithrombotic Therapy in Children*  Journal Articles
• Antithrombotic Therapy in Neonates and Children  Journal Articles
• Antithrombotic Therapy in Neonates and Children  Journal Articles
• Antithrombotic Treatment of Splanchnic Vein Thrombosis: Results of an International Registry  Journal Articles
• Antithrombotic Treatments for Stroke Prevention in Elderly Patients With Nonvalvular Atrial Fibrillation: Drugs and Doses  Journal Articles
• Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines  Journal Articles
• Barriers and facilitators to optimal oral anticoagulant management: a scoping review  Journal Articles
• Bleeding Complications and Management on anticoagulant therapy  Journal Articles
• Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin  Journal Articles
• Bleeding Risk in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Systematic Review and Meta-Analysis  Journal Articles
• Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry  Journal Articles
• Bleeding rates in patients older than 90 years of age on vitamin K antagonist therapy for nonvalvular atrial fibrillation  Journal Articles
• Bleeding risks associated with vitamin K antagonists  Journal Articles
• Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studies  Journal Articles
• Broadening the Categories of Patients Eligible for Extended Venous Thromboembolism Treatment  Journal Articles
• Care of Patients Receiving Long-Term Anticoagulant Therapy  Journal Articles
• Cerebral amyloid angiopathy, cerebral microbleeds and implications for anticoagulation decisions: The need for a balanced approach  Journal Articles
• Clinical Studies with Anticoagulants that Have Changed Clinical Practice  Journal Articles
• Clinical factors influencing the sensitivity to warfarin when restarted after surgery  Journal Articles
• Clinical validation of a new algorithm for computerized dosing of vitamin K antagonist therapy: a retrospective simulation study  Journal Articles
• Coagulopathy in a patient with nephrotic syndrome  Journal Articles
• Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study  Journal Articles
• Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD‐AF and treated with vitamin K antagonists  Journal Articles
• Comparison of treatment effect estimates of non-vitamin K antagonist oral anticoagulants versus warfarin between observational studies using propensity score methods and randomized controlled trials  Journal Articles
• Computerized clinical decision support systems for therapeutic drug monitoring and dosing: A decision-maker-researcher partnership systematic review  Journal Articles
• Cost-effectiveness analysis of dabigatran and anticoagulation monitoring strategies of vitamin K antagonist  Journal Articles
• Current strategies in prophylaxis and treatment of venous thromboembolism  Journal Articles
• Dabigatran and Warfarin in Vitamin K Antagonist–Naive and –Experienced Cohorts With Atrial Fibrillation  Journal Articles
• Dabigatran for stroke prevention in atrial fibrillation: the RE-LY trial  Journal Articles
• Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients Undergoing Cardioversion for Atrial Fibrillation: a Systematic Review and Meta-analysis  Journal Articles
• Direct and indirect costs of management of long‐term warfarin therapy in Canada  Journal Articles
• Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials  Journal Articles
• Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials.  Journal Articles
• Direct oral anticoagulants versus vitamin K antagonists in the first 3 months after bioprosthetic valve replacement: a systematic review and meta-analysis  Journal Articles
• Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation  Journal Articles
• Effect of Vitamin K Intake on the Stability of Treatment with Vitamin K Antagonists: A Systematic Review of the Literature  Journal Articles
• Effect of a simple two‐step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study  Journal Articles
• Effects of sodium warfarin administered during pregnancy in mice  Journal Articles
• Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysis: comment  Journal Articles
• Efficacy and Safety of the Novel Oral Anticoagulants in Atrial Fibrillation  Journal Articles
• Efficacy and safety of apixaban compared with aspirin in patients who previously tried but failed treatment with vitamin K antagonists: results from the AVERROES trial  Journal Articles
• Efficacy and safety of low intensity vitamin K antagonists in Western and East-Asian patients with left-sided mechanical heart valves  Journal Articles
• Emerging anticoagulants for the treatment of venous thromboembolism  Journal Articles
• Evidence-Based Management of Anticoagulant Therapy  Journal Articles
• Evolving Treatments for Arterial and Venous Thrombosis  Journal Articles
• Factor Xa and thrombin as targets for new oral anticoagulants  Journal Articles
• Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards  Journal Articles
• For How Long Should the Treatment with Vitamin K Antagonists Be Maintained?  Conferences
• Four-Factor Prothrombin Complex Concentrate for Urgent Reversal of Vitamin K Antagonists in Patients With Major Bleeding  Journal Articles
• Genotype-guided versus standard vitamin K antagonist dosing algorithms in patients initiating anticoagulation  Journal Articles
• Hemorrhagic Complications of Anticoagulant Treatment  Journal Articles
• Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment  Journal Articles
• Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention  Journal Articles
• Home-monitoring of oral anticoagulation vs. dabigatran  Journal Articles
• How Did We Get Here?: A Historical Review and Critical Analysis of Anticoagulation Therapy Following Mechanical Valve Replacement  Journal Articles
• How can we reduce disagreement among guidelines for venous thromboembolism prevention?  Journal Articles
• Hypercoagulable state and thromboembolism following warfarin withdrawal in post-myocardial-infarction patients  Journal Articles
• Iatrogenic causes of an ICH  Journal Articles
• Impact of Switching From a Vitamin K Antagonist to Rivaroxaban on Satisfaction With Anticoagulation Therapy: The XANTUS‐ACTS Substudy  Journal Articles
• Impact of cost on use of non-vitamin K antagonists in atrial fibrillation patients in Ontario, Canada  Journal Articles
• Incidence of Cancer after Prophylaxis with Warfarin against Recurrent Venous Thromboembolism  Journal Articles
• Incidence of intracranial bleeding in anticoagulated patients with minor head injury: a systematic review and meta‐analysis of prospective studies  Journal Articles
• Initial treatment of venous thromboembolism  Journal Articles
• Laboratory Monitoring of Oral Vitamin K Anticoagulation  Journal Articles
• Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation  Journal Articles
• Low Dose Oral Vitamin K to Reverse Acenocoumarol-induced Coagulopathy: A Randomized Controlled Trial  Journal Articles
• Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial.  Journal Articles
• Low-dose Oral Vitamin K Reliably Reverses Over-anticoagulation due to Warfarin  Journal Articles
• Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10  Journal Articles
• Low-dose oral vitamin K therapy for the management of asymptomatic patients with elevated international normalized ratios: a brief review  Journal Articles
• Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin  Journal Articles
• Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review  Journal Articles
• Management of Bleeding Complications in the Anticoagulated Patient  Journal Articles
• Management of Bleeding in Patients with Advanced Cancer  Journal Articles
• Management of Excessive Anticoagulant Effect Due to Vitamin K Antagonists  Journal Articles
• Management of bleeding complications in patients with cancer on DOACs  Journal Articles
• Maturation of the hemostatic system during childhood  Journal Articles
• Mechanism of Action and Monitoring of Anticoagulants  Journal Articles
• Meta‐Analysis of Continuous Oral Anticoagulants Versus Heparin Bridging in Patients Undergoing CIED Surgery: Reappraisal after the BRUISE Study  Journal Articles
• Monitoring patients with the lupus anticoagulant while treated with vitamin K antagonists: communication from the SSC of the ISTH  Journal Articles
• Mortality in vitamin K antagonist-related intracerebral bleeding treated with plasma or 4-factor prothrombin complex concentrate  Journal Articles
• Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta‐analysis of randomized controlled trials  Journal Articles
• Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W  Journal Articles
• NOACs for treatment of venous thromboembolism in clinical practice  Journal Articles
• NOACs only for those who cannot tolerate a VKA: where is the evidence?  Journal Articles
• Natural history of mesenteric venous thrombosis in patients treated with vitamin K antagonists  Journal Articles
• Net Clinical Benefit of Adding Clopidogrel to Aspirin Therapy in Patients With Atrial Fibrillation for Whom Vitamin K Antagonists Are Unsuitable  Journal Articles
• New Anticoagulants for Atrial Fibrillation  Journal Articles
• New Antithrombotic Drugs  Journal Articles
• New anticoagulants: an update.  Journal Articles
• New artificial intelligence prediction model using serial prothrombin time international normalized ratio measurements in atrial fibrillation patients on vitamin K antagonists: GARFIELD-AF  Journal Articles
• New developments in anticoagulants: Past, present and future  Journal Articles
• New oral anticoagulants in elderly patients  Journal Articles
• New oral anticoagulants versus vitamin K antagonists for treatment of acute venous thromboembolism: do they really increase the incidence of myocardial infarction?  Journal Articles
• New oral anticoagulants: A view from the laboratory  Journal Articles
• New pharmacotherapy for stroke prevention in atrial fibrillation: Update 2010  Journal Articles
• Non-Vitamin K Antagonist Oral Anticoagulants  Journal Articles
• Non-variceal upper gastrointestinal bleeding  Journal Articles
• Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel  Journal Articles
• Non-vitamin-K oral anticoagulants (NOACs) for the prevention of secondary stroke  Journal Articles
• Nonheparin Anticoagulants for Heparin-Induced Thrombocytopenia  Journal Articles
• Novel Oral Factor Xa and Thrombin Inhibitors in the Management of Thromboembolism  Journal Articles
• Novel anticoagulant agents: introduction  Journal Articles
• Optimal Anticoagulation for Pregnant Women with Mechanical Heart Valves  Journal Articles
• Optimal reversal of vitamin K antagonists  Journal Articles
• Optimal timing of vitamin K antagonist resumption after upper gastrointestinal bleeding  Journal Articles
• Optimal treatment duration of venous thrombosis  Journal Articles
• Oral Anticoagulant Therapy  Journal Articles
• Oral Anticoagulants  Journal Articles
• Oral Rivaroxaban for Symptomatic Venous Thromboembolism  Journal Articles
• Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism  Journal Articles
• Oral Vitamin K Lowers the International Normalized Ratio More Rapidly Than Subcutaneous Vitamin K in the Treatment of Warfarin-Associated Coagulopathy  Journal Articles
• Oral Vitamin K Versus Placebo to Correct Excessive Anticoagulation in Patients Receiving Warfarin  Journal Articles
• Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range  Journal Articles
• Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10  Journal Articles
• Oral vitamin K for warfarin-associated coagulopathy.  Journal Articles
• Oral vitamin K produces a normal INR within 24 hours of its administration in most patients discontinuing warfarin.  Journal Articles
• Orally Active Direct Thrombin Inhibitors  Journal Articles
• Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials  Journal Articles
• Outcomes of Temporary Interruption of Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation  Journal Articles
• Patients on vitamin K treatment: is switching to direct-acting oral anticoagulation cost-effective? A target trial on a prospective cohort  Journal Articles
• Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients  Journal Articles
• Perioperative Management of Antithrombotic Therapy  Journal Articles
• Perioperative Management of Vitamin K Antagonists and Direct Oral Anticoagulants  Journal Articles
• Periprocedural Heparin Bridging in Patients Receiving Vitamin K Antagonists  Journal Articles
• Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery  Journal Articles
• Pharmacologic tools to reduce bleeding in surgery.  Journal Articles
• Pharmacology and Management of the Vitamin K Antagonists  Journal Articles
• Portal vein thrombosis in patients with cirrhosis: underdiagnosis and undertreatment?  Journal Articles
• Position Statement: Guidelines for vitamin K prophylaxis in newborns: A joint statement of the Canadian Paediatric Society and the College of Family Physicians of Canada.  Journal Articles
• Post‐thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months  Journal Articles
• Potential antidotes for reversal of old and new oral anticoagulants  Journal Articles
• Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failure  Conferences
• Practical management of coagulopathy associated with warfarin  Journal Articles
• Practical management of coagulopathy associated with warfarin.  Journal Articles
• Praktische Behandlung der Warfarin-assoziierten Gerinnungsstörung  Journal Articles
• Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)  Journal Articles
• Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF  Journal Articles
• Prevalence of Low Bone Mass and Deficiencies of Vitamins D and K in Pediatric Patients With Cystic Fibrosis From 3 Canadian Centers  Journal Articles
• Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention  Journal Articles
• Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment  Journal Articles
• Prevention of venous thromboembolism after major orthopedic surgery: summing up evidence about old and new antithrombotic agents  Journal Articles
• Profile of betrixaban and its potential in the prevention and treatment of venous thromboembolism  Journal Articles
• Prolonged Prothrombin Time and Partial Thromboplastin Time in Disseminated Intravascular Coagulation not Due to Deficiency of Factors V and VIII  Journal Articles
• Prothrombin Complex Concentrates for Perioperative Vitamin K Antagonist and Non–vitamin K Anticoagulant Reversal  Journal Articles
• Prothrombin complex concentrate (PCC, Octaplex®) in patients requiring immediate reversal of vitamin K antagonist anticoagulation  Journal Articles
• Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry  Journal Articles
• RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate  Journal Articles
• Randomized controlled trials of new oral anticoagulants for stroke prevention in atrial fibrillation  Journal Articles
• Rapid diagnosis of coagulopathies from vitamin K deficiency in a consecutive case cohort evaluated by comparative assessment of factor II by one stage assays with prothrombin time versus Ecarin reagents  Journal Articles
• Rapid reversal of haematoma expansion associated with vitamin K antagonists  Journal Articles
• Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment  Journal Articles
• Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis  Journal Articles
• Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: A randomized trial  Journal Articles
• Reply: Can Bisphosphonates Prevent Vitamin K Antagonist Toxicity in Patients with Idiopathic Pulmonary Fibrosis?  Journal Articles
• Residual Vein Thrombosis and D-Dimer for Optimizing Duration of Anticoagulation in Idiopathic Deep Vein Thrombosis  Journal Articles
• Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: The extended DACUS study  Journal Articles
• Reversal agents for current and forthcoming direct oral anticoagulants  Journal Articles
• Reversal of Warfarin  Journal Articles
• Reversal of the Anticoagulant Effects of Warfarin by Vitamin K1  Journal Articles
• Reversal of vitamin K antagonist-associated coagulopathy: A survey of current practice  Journal Articles
• Reversing anticoagulants both old and new.  Journal Articles
• Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry  Journal Articles
• Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants  Journal Articles
• Risk of bleeding with vitamin K antagonists compared with low-molecular-weight heparin after orthopedic surgery: a rebuttal  Journal Articles
• Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation  Journal Articles
• Safe bridging to warfarin in heparin-induced thrombocytopenia  Journal Articles
• Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists  Journal Articles
• Should vitamin K antagonist therapy be started simultaneously with parenteral anticoagulation  Journal Articles
• Should vitamin K be administered when HIT is diagnosed after administration of coumarin?  Journal Articles
• Single-Arm Study of Bridging Therapy With Low-Molecular-Weight Heparin for Patients at Risk of Arterial Embolism Who Require Temporary Interruption of Warfarin  Journal Articles
• Small intestinal bacterial overgrowth and warfarin dose requirement variability  Journal Articles
• Solving the mystery of excessive warfarin-induced bleeding: A personal historical perspective  Journal Articles
• Successful treatment with rFVIIa of spontaneous intracerebral hemorrhage in a patient with mechanical prosthetic heart valves  Journal Articles
• Systematic Review of Observational Studies Assessing Bleeding Risk in Patients with Atrial Fibrillation Not Using Anticoagulants  Journal Articles
• Taking our vitamins  Journal Articles
• The Canadian Home Total Parenteral Nutrition (HTPN) Registry  Journal Articles
• The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation  Journal Articles
• The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V—Special Situations  Journal Articles
• The Perioperative Management of Antithrombotic Therapy  Journal Articles
• The Pharmacology and Management of the Vitamin K Antagonists  Journal Articles
• The Risk of Hemorrhage Among Patients With Warfarin-Associated Coagulopathy  Journal Articles
• The accuracy of the International Normalized Ratio and the American College of Chest Physicians recommendations on the use of vitamin K to reverse over-anticoagulation: a rebuttal  Journal Articles
• The effect of low-dose oral vitamin K supplementation on INR stability in patients receiving warfarin  Journal Articles
• The historical origins of modern international normalized ratio targets  Journal Articles
• The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis  Journal Articles
• The management of patients who require temporary reversal of vitamin K antagonists for surgery: a practical guide for clinicians  Journal Articles
• The prognostic utility of ICH-score in anticoagulant related intracerebral hemorrhage  Journal Articles
• The risk of ipsilateral versus contralateral recurrent deep vein thrombosis in the leg  Journal Articles
• The risk of ipsilateral versus contralateral recurrent deep vein thrombosis in the leg. The DURAC Trial Study Group.  Journal Articles
• The use of vitamin K in the perinatal period. Fetus and Newborn Committee, Canadian Paediatric Society.  Journal Articles
• Thrombin and Antithrombotics  Journal Articles
• Thrombophilia and location of venous thromboembolism  Journal Articles
• Thrombosis in Children  Journal Articles
• Transition from apixaban to warfarin—addressing excess stroke, systemic embolism, and major bleeding  Journal Articles
• Treatment and Prevention of Heparin-Induced Thrombocytopenia  Journal Articles
• Treatment of Warfarin-Associated Coagulopathy  Journal Articles
• Treatment of bleeding complications in patients on anticoagulant therapy  Journal Articles
• Treatment of coumarin‐associated coagulopathy: a systematic review and proposed treatment algorithms  Journal Articles
• Treatment of venous thromboembolic disease.  Journal Articles
• Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial  Journal Articles
• Treatment of warfarin-associated coagulopathy with vitamin K  Journal Articles
• Tumorkrankheit, Thromboembolien und antithrombotische Therapie: Gibt es ein Antikoagulans der Wahl?  Journal Articles
• Unanswered questions in venous thromboembolism  Journal Articles
• Unresolved issues in the use of direct acting oral anticoagulants  Journal Articles
• Validation of a Food Frequency Questionnaire for Bone Nutrients in Pregnant Women  Journal Articles
• Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy  Journal Articles
• Venous thromboembolism management: where do novel anticoagulants fit?  Journal Articles
• Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism  Journal Articles
• Vitamin K Antagonists and Risk of Subdural Hematoma  Journal Articles
• Vitamin K antagonists and cancer: rebuttal  Journal Articles
• Vitamin K antagonists in heart disease: Current status and perspectives (Section III)  Journal Articles
• Vitamin K for reversal of excessive vitamin K antagonist anticoagulation: a systematic review and meta-analysis  Journal Articles
• Vitamin K for the Treatment of Asymptomatic Coagulopathy Associated with Oral Anticoagulant Therapy  Conferences
• Vitamin K in anticoagulation therapy  Journal Articles
• Vitamin K to reverse the anticoagulant effect of vitamin K antagonists: can you teach an old dog new tricks?  Journal Articles
• Vitamin K versus warfarin interruption alone in patients without bleeding and an international normalized ratio > 10  Journal Articles
• Warfarin Cessation Before Cardiopulmonary Bypass: Lessons Learned from a Randomized Controlled Trial of Oral Vitamin K  Journal Articles
• Warfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility  Journal Articles
• Warfarin faring better: vitamin K antagonists beat rivaroxaban and apixaban in the INVICTUS and PROACT Xa trials  Journal Articles
• Warfarin-induced venous limb ischemia/gangrene complicating cancer: a novel and clinically distinct syndrome  Journal Articles
• When Direct Oral Anticoagulants Should Not Be Standard Treatment  Journal Articles
• When the Rubber Meets the Road: Adherence and Persistence with Non–Vitamin K Antagonist Oral Anticoagulants and Old Oral Anticoagulants in the Real World—A Problem or A Myth ?  Journal Articles
• XALIA-LEA: An observational study of venous thromboembolism treatment with rivaroxaban and standard anticoagulation in the Asia-Pacific, Eastern Europe, the Middle East, Africa and Latin America  Journal Articles
• Ximelagatran or Warfarin for Stroke Prevention in Patients With Atrial Fibrillation?  Journal Articles
• [Anticoagulants and other drugs effective against thrombosis].  Journal Articles
• [Treatment of venous thrombo--emboli].  Journal Articles